Literature DB >> 25014245

Nephron-sparing surgery for multifocal and hereditary renal tumors.

Adam R Metwalli1, William M Linehan.   

Abstract

PURPOSE OF REVIEW: Despite the controversy surrounding the benefits of nephron-sparing surgery, multiple absolute indications for nephron-sparing surgery still exist, including the classic indications of hereditary and bilateral kidney tumors. RECENT
FINDINGS: Multiple genetic mutations have been identified which lead to hereditary kidney cancer conditions. These are briefly reviewed because the surgical management of hereditary kidney tumors depends on the genetic and histologic subtypes involved. Clear understanding of these hereditary conditions is crucial for proper surgical management of these tumors.
SUMMARY: Complex partial nephrectomy for multiple renal tumors, or multiplex partial nephrectomy, requires not only exceptional surgical skills but expertise of numerous nonsurgical methodologies, such as hands-on intraoperative ultrasonography and interpretation of multiple imaging modalities. In addition, multidisciplinary management is crucial for optimal outcomes in patient care. This review evaluates the most advanced surgical techniques and perioperative management required to successfully care for these challenging cases.

Entities:  

Mesh:

Year:  2014        PMID: 25014245      PMCID: PMC4441729          DOI: 10.1097/MOU.0000000000000094

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  78 in total

1.  Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis.

Authors:  Nnenaya Q Agochukwu; Adam R Metwalli; Alexander Kutikov; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2012-09-19       Impact factor: 7.450

2.  Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome.

Authors:  Christian P Pavlovich; Robert L Grubb; Kathleen Hurley; Gladys M Glenn; Jorge Toro; Laura S Schmidt; Carlos Torres-Cabala; Maria J Merino; Berton Zbar; Peter Choyke; McClellan M Walther; W Marston Linehan
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

3.  Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience.

Authors:  Tobias Klatte; Heiko Wunderlich; Jean-Jacques Patard; Mark D Kleid; John S Lam; Kerstin Junker; Jörg Schubert; Malte Böhm; Ernst P Allhoff; Fairooz F Kabbinavar; Maxime Crepel; Luca Cindolo; Alexandre De La Taille; Jacques Tostain; Arnaud Mejean; Michel Soulie; Laurent Bellec; Jean Christophe Bernhard; Jean-Marie Ferriere; Christian Pfister; Baptiste Albouy; Marc Colombel; Amnon Zisman; Arie S Belldegrun; Allan J Pantuck
Journal:  BJU Int       Date:  2007-04-13       Impact factor: 5.588

4.  Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma.

Authors:  Sakari Vanharanta; Mary Buchta; Sarah R McWhinney; Sanna K Virta; Mariola Peçzkowska; Carl D Morrison; Rainer Lehtonen; Andrzej Januszewicz; Heikki Järvinen; Matti Juhola; Jukka-Pekka Mecklin; Eero Pukkala; Riitta Herva; Maija Kiuru; Nina N Nupponen; Lauri A Aaltonen; Hartmut P H Neumann; Charis Eng
Journal:  Am J Hum Genet       Date:  2003-12-18       Impact factor: 11.025

Review 5.  Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.

Authors:  David S Dimarco; Christine M Lohse; Horst Zincke; John C Cheville; Michael L Blute
Journal:  Urology       Date:  2004-09       Impact factor: 2.649

Review 6.  von Hippel-Lindau disease.

Authors:  Russell R Lonser; Gladys M Glenn; McClellan Walther; Emily Y Chew; Steven K Libutti; W Marston Linehan; Edward H Oldfield
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

7.  Initial experience with robot assisted partial nephrectomy for multiple renal masses.

Authors:  Ronald Boris; Miguel Proano; W Marston Linehan; Peter A Pinto; Gennady Bratslavsky
Journal:  J Urol       Date:  2009-08-14       Impact factor: 7.450

8.  Germline SDHB mutations and familial renal cell carcinoma.

Authors:  Christopher Ricketts; Emma R Woodward; Pip Killick; Mark R Morris; Dewi Astuti; Farida Latif; Eamonn R Maher
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

9.  Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.

Authors:  Christopher J Ricketts; Brian Shuch; Cathy D Vocke; Adam R Metwalli; Gennady Bratslavsky; Lindsay Middelton; Youfeng Yang; Ming-Hui Wei; Stephen E Pautler; James Peterson; Catherine A Stolle; Berton Zbar; Maria J Merino; Laura S Schmidt; Peter A Pinto; Ramaprasad Srinivasan; Karel Pacak; W Marston Linehan
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

Review 10.  Multicentricity in renal cell carcinoma.

Authors:  I Nissenkorn; J Bernheim
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

View more
  10 in total

1.  Re: Multiple Tumor Excisions in Ipsilateral Kidney Increase Complications After Partial Nephrectomy (From: Maurice MJ, Ramirez D, Nelson R, et al. J Endourology 2016;30:1200-1206).

Authors:  Adam R Metwalli
Journal:  J Endourol       Date:  2017-07-20       Impact factor: 2.942

Review 2.  Therapeutic Strategies for Hereditary Kidney Cancer.

Authors:  Abhinav Sidana; Ramaprasad Srinivasan
Journal:  Curr Oncol Rep       Date:  2016-08       Impact factor: 5.075

3.  Clinical outcomes of percutaneous radiofrequency ablation for small renal cancer.

Authors:  Keiichi Ito; Shigeyoshi Soga; Kenji Seguchi; Yusuke Shinchi; Ayako Masunaga; Shinsuke Tasaki; Kenji Kuroda; Akinori Sato; Junichi Asakuma; Akio Horiguchi; Hiroshi Shinmoto; Tatsumi Kaji; Tomohiko Asano
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

4.  What is the Optimal Management Strategy for Multifocal and Hereditary Kidney Cancer?

Authors:  Joseph A Baiocco; Adam R Metwalli
Journal:  J Ren Med       Date:  2017-04-01

5.  Postoperative elevation in creatine kinase and its impact on renal function in patients undergoing complex partial nephrectomy.

Authors:  Abhinav Sidana; Annerleim Walton-Diaz; Hong Truong; M Minhaj Siddiqui; Ning Miao; Johanna Shih; Andrew Mannes; Gennady Bratslavsky; W Marston Linehan; Adam R Metwalli
Journal:  Int Urol Nephrol       Date:  2016-04-19       Impact factor: 2.370

6.  Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.

Authors:  Mark W Ball; Julie Y An; Patrick T Gomella; Rabindra Gautam; Christopher J Ricketts; Cathy D Vocke; Laura S Schmidt; Maria J Merino; Ramaprasad Srinivasan; Ashkan A Malayeri; Adam R Metwalli; W Marston Linehan
Journal:  J Clin Oncol       Date:  2020-02-21       Impact factor: 44.544

7.  Managing Renal Cell Carcinoma Associated Paraneoplastic Syndrome with Nephron-sparing Surgery in a Patient with von Hippel-Lindau.

Authors:  John M DiBianco; Julie Y An; Sally Tanakchi; Zachary Stanik; Aidan McGowan; Mahir Maruf; Abhinav Sidana; Amit Lodha Jain; Akhil Muthigi; Arvin K George; Christopher Bayne; W Marston Linehan; Shawna L Boyle; Adam R Metwalli
Journal:  Urol Case Rep       Date:  2017-04-27

8.  Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma.

Authors:  Kenan Ashouri; Sophia Mohseni; John Tourtelot; Pranav Sharma; Philippe E Spiess
Journal:  J Kidney Cancer VHL       Date:  2015-09-25

Review 9.  Molecular genetic testing strategies used in diagnostic flow for hereditary endocrine tumour syndromes.

Authors:  Henriett Butz; Jo Blair; Attila Patócs
Journal:  Endocrine       Date:  2021-02-11       Impact factor: 3.633

Review 10.  Multiplex Partial Nephrectomy, Repeat Partial Nephrectomy, and Salvage Partial Nephrectomy Remain the Primary Treatment in Multifocal and Hereditary Kidney Cancer.

Authors:  Joseph A Baiocco; Adam R Metwalli
Journal:  Front Oncol       Date:  2017-10-20       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.